SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: john dixon who wrote (2938)3/9/1999 9:57:00 AM
From: shero  Read Replies (1) of 3702
 
I think its a good deal, in fact better than I would have thought, all things considered.

BTD comprised is agreement allowing TCLN to keep more up front cash. The burn rate is reduced as 80% of the costs of the trials are being paid for by our new partner. With this cash and the latest draw down from the "LOC" the company may not have to draw-down or issue more stock for awhile.

And it shows outside interest in licensing VTA, another TCLN platform technology. And most important it STARTS to establish some credibily for "new" management, something that has been missing for years.

All in all, I find this very encouraging.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News